News

The virtual care company disclosed all-time-high revenue and membership growth during 2020, yet offered 2021 projections below what investors anticipated.
By  Dave Muoio 03:44 pm February 25, 2021
The virtual care company disclosed all-time-high revenue and membership growth during 2020, yet offered 2021 projections below what investors anticipated.
Health investments
By  Laura Lovett 02:43 pm February 25, 2021
Also: Medisafe lands $30 million in a round led by Sanofi and January AI rakes in $8.8 million for glycemic response tool. 
By  Dave Muoio 02:06 pm February 25, 2021
Industry regulatory leaders outline the best approaches for digital health companies looking to make sense of FDA's long-in-the-tooth enforcement discretion guidelines.
Panelists from DTx West share how they successfully executed a digital therapeutic and payer relationship.
By  Mallory Hackett 12:20 pm February 25, 2021
Panelists from DTx West share how they successfully executed a digital therapeutic and payer relationship.   
Respiray’s wearable device

Credit: Respiray

By  Sophie Porter 12:59 am February 25, 2021
Respiray’s wearable device allegedly kills over 99% of viruses and bacteria with UV light and filter.
Digital research
By  Laura Lovett 03:07 pm February 24, 2021
Panelists at this morning's DTx West discuss how governments worldwide are looking at digital therapeutics.  
A person uses an AppliedVR-branded virtual reality headset
By  Dave Muoio 02:56 pm February 24, 2021
In a recent study funded and coauthored by the company, the EaseVRx program outperformed a non-interactive headset app across several self-reported pain and pain-interference measures.
Medication delivery is currently available in metro areas of New York City, Chicago, Minneapolis, Boston and Austin.
By  Mallory Hackett 01:37 pm February 24, 2021
Medication delivery is currently available in metro areas of New York City, Chicago, Minneapolis, Boston and Austin.   
NHSX, NHS
By  Tammy Lovell 11:03 am February 24, 2021
The process aims to ensure tools meet NHS standards.
By  Dave Muoio 09:00 am February 24, 2021
The randomized controlled trial of the jointly-developed digital therapeutics will be conducted using Verily's Project Baseline and enroll up to 540 patients.